Introduction
============

Colorectal polyps is a general term used for all the neoplasms protruding from the intestine. Colorectal polyps have a high incidence rate globally, and the detection rate of colonoscopy is 10--20%. Among the patients with colorectal polyps, there are more male patients than females because colorectal polyps are closely related to intestinal cancer ([@b1-ol-0-0-10120],[@b2-ol-0-0-10120]). In Gastroenterology, large intestine polyps are often diagnosed and their incidence rates are constantly increasing ([@b3-ol-0-0-10120]). When the growth and death of colorectal epithelial cells are out of balance, and a certain degree of abnormal surface mucosal hyperplasia occurs, intestinal polyps emerge ([@b4-ol-0-0-10120]). Gastrointestinal polyps are roughly classified into pedicle and broad-based polyps according to their shapes ([@b5-ol-0-0-10120]). There are documents showing that proliferation of adenoma cancer is a general pattern of colon cancer development ([@b6-ol-0-0-10120]). Therefore, early detection, early treatment and post-treatment follow-up of colorectal polyps are particularly important ([@b7-ol-0-0-10120]).

With the rapid development of endoscopic treatment technology, endoscopic mucosal resection (EMR) has become the most common polypectomy technique, which is easy to operate and less painful for the patients. It is recognized as a method that is very safe and does less harm to patients. Also it is very convenient to operate ([@b8-ol-0-0-10120]) and has been widely used in clinics ([@b9-ol-0-0-10120]). High-frequency electric cutting is not easy under endoscopy, and there is a risk of perforation and hemorrhage. If liquid is injected into the bottom of the polyp, a layer of liquid pad is created and the polyp ascends, which can reduce the incidence rates of complications ([@b5-ol-0-0-10120]). It has been reported that the use of submucosal injections during surgery can separate the muscularis propria and mucosa layer. As a result, the boundary between the normal mucosa and the polyp mucosa becomes more obvious, which is beneficial in order to better grasp the range of the snare during surgery and polyp residues can be prevented. Moreover, the difference in the maintenance time of different submucosal injection fluid pads directly affects the surgical operation and wound healing ([@b10-ol-0-0-10120]). In recent years, the use of high-frequency electrocoagulation for the submucosal injection of saline is the most widely used method. It is also very easy to operate, and is a safe and effective mucosal resection method ([@b11-ol-0-0-10120]). The injection of normal saline and the tissue fluid are in an isotonic state, so they have a good compatibility. However, as the osmotic pressure of normal saline and tissue is the same, the endoscopic liquid pad disappears too fast during the resection process, which requires multiple injections and therefore leads to substantial inconvenience during the surgery ([@b12-ol-0-0-10120]). Glycerol fructose is a commonly used submucosal injection in clinical practice and is a hypertonic solution. Submucosal injection can reduce the risk of perforation and hemorrhage. Submucosal injection of glycerol fructose during endoscopic surgery does not stimulate tumor cell proliferation at the area of the wound, and its mucosal elevation is higher and longer than normal saline ([@b13-ol-0-0-10120]).

This study explored many aspects, such as the complications and resection rates. The effect of submucosal injection of normal saline and glycerol fructose on endoscopic polypectomy in patients with large intestine was compared.

Patients and methods
====================

### General information

A total of 275 patients with colorectal polyps who underwent endoscopic polypectomy from March 2013 to December 2016 were assigned. Among them, 150 cases who were treated with submucosal injection of glycerol fructose were set as the experimental group, including 98 cases of male patients and 52 cases of female patients, with an average age of 58.2±6.12 years and average polyp diameter 0.93±0.23 cm. There were 44 multiple cases, 106 single cases, 78 cases of hypertrophic polyp, 59 cases of benign polyp and 13 cases of adenomatous polyp in this group. A total of 125 cases who were treated with submucosal injection of normal saline were set as the control group, including 70 cases of male patients and 55 cases of female patients, with an average age of 58.8±5.98 years and average polyp diameter 0.98±0.21 cm. There were 35 multiple cases, 90 single cases, 66 cases of hypertrophic polyp, 49 cases of benign polyp and 10 cases of adenomatous polyp in this group.

Inclusion criteria: i) patients who met the diagnostic criteria for intestinal polyps ([@b14-ol-0-0-10120]); ii) with complete basic clinical information; iii) with polyp diameter \<2.5 cm; iv) for which the submucosal fluid injection showed a positive sign; and v) who underwent routine examination before surgery.

Exclusion criteria: i) patients who were not actively receiving treatment; ii) with endoscopy and contraindications for treatment; iii) pregnant women; iv) patients with severe medical conditions who could not undergo surgery; and v) patients with malignant tumors, thrombocytopenia, and coagulopathy.

The study was approved by the Ethics Committee of Qingdao Chengyang People\'s Hospital (Qingdao, China). The experimental procedures were described to the patients in detail, and signed informed consents were obtained from the patients or their guardians.

### Main drugs and instruments

Fujinon 200 series electronic colonoscope (Fujifilm Corp., Tokyo, Japan), ERBE (ICC 80) high-frequency generator (Erbe Elektromedizin GmbH, Tuebingen, Germany), Olympus disposable polyp snare (Olympus Corp., Tokyo, Japan), injection needle (Cook Regentec, Indianapolis, IN, USA), adrenaline (national medicine Zhunzi H11020584; Beijing Yongkang Pharmaceutical Co., Ltd., Beijing, China), methylene blue (National Pharmaceutical Standard H32024827; Jiangsu Jumpcan Pharmaceutical Co., Ltd., Jiangsu, China), sodium chloride solution (H20056130; Beijing Shuanghe Pharmaceutical Co., Ltd., Beijing, China), glycerol fructose (National Pharmaceutical Standard H20043355; Zhejiang Tianrui Pharmaceutical Co., Ltd., Zhejiang, China).

### Methods of treatment

Patient information was recorded and medical history was requested before surgery. For patients with constipation, oral phenolphthalein tablets were given before surgery (2 pieces/time, 1 or 2 times/day), applying 25 ml of castor oil before taking the intestinal washing solution (3,000 ml). The method of clyster was used for patients who could not take the intestinal washing solution. Patients underwent intramuscular injection of 10 mg diazepam (National Pharmaceutical Standard H41020631; Tianjin Pharmaceutical Co., Ltd., Tianjin, China) and 10 mg anisodamine (National Drug Standard H0000002121; Hangzhou Minsheng Pharmaceutical Co., Ltd., Hangzhou, China). Oral mannitol was not taken when cleaning the enema. The four factors of coagulation, electrocardiogram and blood routine were performed simultaneously. For older patients, ECG monitoring was also required during surgery. After the polyps were found, the feces around the polyps were first drained, the amount of inflation was increased, and it was determined whether the polyps were suitable for high-frequency electrotherapy. The snare was inserted to the biopsy hole keeping the distance between the end of inner lens and the polyp to \~2 cm. The submucosal injection for the observation group was 38 ml of glycerol fructose, and for the control group was 38 ml of normal saline, adding 0.4 ml of methylene blue (10 g/l) and 2 ml of epinephrine (1 g/l) for both groups. Before the polyp was removed, the submucosal injection was performed at a penetration angle of \<40° until the polyp was fully lifted for resection. Polyps \>2 cm usually take a one-time excision or partial resection. In order to maintain the bulging state during the resection process, the injection was repeated. If the submucosal injection did not allow the lesion to remain in a raised state, then the operation needed to be terminated and converted to a surgical operation. After the polyp was removed, the wound was observed for 1--3 min until the bleeding was stopped. After surgery, patients rested and routinely antacids or antibacterials were applied. Crude fiber foods and physical activities within 2 weeks should be avoided.

### Observation indexes

The operation time, the number of repeated injections, the amount of fluid used for pad injection, the time of anesthesia and dosage, the en bloc resection rate (EBRR) and the complete resection rate (CRR) were recorded. Then, the postoperative complications and the total length of hospitalization were observed. Patients were followed up for 3 months and their recurrence was recorded until the deadline in March 2017.

### Statistical analysis

Statistical analysis of experimental data was performed using SPSS 17.0 statistical software (SPSS, Inc., Chicago, IL, USA). Data counting was expressed in n (%), and Chi-square test was used to compare the differences between the experimental and control group. The measurement data were expressed as the mean ±standard deviation and paired t-test was used to compare the differences between the experimental and control group. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Comparison of general data between the groups

As shown in [Table I](#tI-ol-0-0-10120){ref-type="table"}, there were no significant differences in terms of sex, average age, average weight, average height, smoking or non-smoking, alcoholic or non-alcoholic, average polyp diameter, pathological examination classification, pathological type, and location of the disease between the two groups (P\>0.05), which suggested that the two groups were comparable.

### Comparison of surgery time between the groups

There was no significant difference (P\>0.05) in the time until the surgical colonscope insertion reached the ileocecal valve between the two groups. The time of polyp treatment and the total surgery time (anesthesia time) in the experimental group were shorter than those in the control group, and the differences were statistically significant (t=39.76 and 20.46, respectively; P\<0.05). The number of repeated injections in the experimental group was less than that in the control group, and the difference was statistically significant (t=5.875, P\<0.05; [Table II](#tII-ol-0-0-10120){ref-type="table"}).

### Comparison of the amount of fluid and propofol injected into patients of the two groups

The amount of fluid used for pad injection and the amount of propofol used during anesthesia were significantly lower in the experimental group than that in the control group, and the differences between the two groups were statistically significant. (t=38.12 and 4.463, respectively; P\<0.05; [Table III](#tIII-ol-0-0-10120){ref-type="table"}).

### Comparison of resection rates between the groups

EBRR and CRR in the experimental group were 68.0 and 48.0%, respectively. EBRR and CRR in the control group were 49.6 and 27.2%, respectively. As shown in [Fig. 1](#f1-ol-0-0-10120){ref-type="fig"}, EBRR and CRR in the experimental group were higher than those in the control group, and the differences were statistically significant (P\<0.05).

### Comparison of complications between the groups

There was no perforation in the two groups of patients during surgery. Intraoperative hemorrhage occurred in 2 patients who underwent surgery and hemostasis was successful under endoscopy. In the control group, 1 patient developed postoperative hemorrhage on the 3rd day after surgery, but the amount of blood loss was small. When colonoscopy was performed again, there was a blood clot in the area of the wound and blood loss was stopped. There was no need for endoscopic hemostasis and the patient was successfully discharged on the 5th day after surgery. Specific postoperative complications observed in the two groups are shown in [Table IV](#tIV-ol-0-0-10120){ref-type="table"}. There was no significant difference in the incidence of postoperative complications between the two groups (P\>0.05).

### Comparison of average length of hospitalization and recurrence rate between the groups

There was no significant difference in the average length of hospitalization between the two groups (t=1.603, P\>0.05). After surgery, patients were followed up for 3 months by telephone and revisiting the hospital. There was no relapse in the experimental group and only 2 patients relapsed in the control group, who were healed after treatment. There was no significant difference in the recurrence rate between the two groups (χ^2^=2.02, P\>0.05; [Table V](#tV-ol-0-0-10120){ref-type="table"}).

Discussion
==========

Colorectal polyps are new organisms that originate in the colon and rectal mucosa protruding into the lumen. It is a common disease of the digestive system, and the risk of developing colorectal polyps increases with age ([@b15-ol-0-0-10120]). Pathologically, they can be divided into adenomatous and non-adenomatous polyps. Currently, it is believed that most cases of colorectal cancer are evolved from intestinal polyps. However, adenomatous polyps account for the majority of them ([@b16-ol-0-0-10120],[@b17-ol-0-0-10120]). As age increases, the rate of polyps and the rate of malignant transformations also increase ([@b18-ol-0-0-10120]). There are also documents showing that the appearance of colorectal polyps may indicate the emergence of other diseases ([@b19-ol-0-0-10120]). Therefore, the early treatment of colorectal polyps is particularly important.

EMR is the primary treatment for colorectal polyps and can significantly reduce the risk of death from colorectal cancer ([@b20-ol-0-0-10120]). However, there are still risks involved in the surgery, such as infection and perforation, and especially hemorrhage which is a common complication ([@b21-ol-0-0-10120]). Therefore, good endoscopic skills and clinical judgment are important during surgery ([@b22-ol-0-0-10120]), and relevant measures to reduce the occurrence of complications should be taken. Injecting certain submucosal during EMR surgery can reduce complications and make surgery more convenient. The submucosal injections used in clinical practice are mainly normal saline and glycerin fructose. Also glycerol fructose is a hypertonic solution that has no adverse reactions to various systems and is widely used clinically ([@b23-ol-0-0-10120]).

In this study, there was no significant difference in the general clinical information between the experimental and control group. The surgery time in the experimental group was shorter than that in the control group. The number of repeated injections in the experimental group was less than that in the control group, and the difference was statistically significant (P\<0.05). This indicates that glycerol fructose has a longer rising time on the mucosa than normal saline. Animal studies have shown that hypertonic solutions, other than glycerol fructose, can cause tissue damage to the mucosa ([@b24-ol-0-0-10120]). By comparing the amount of fluid and propofol injected in the two groups, we found that the amount used in the experimental group was less than that in the control group. Since normal saline has the same osmotic pressure as that of the tissue, the dispersion was fast. However, since glycerol fructose is a hypertonic solution that prolongs the time of the fluid pad, the number of injections were reduced. Propofol is mainly used for induction and maintenance of anesthesia and is a commonly used drug during anesthesia. It has the advantages of strong anesthesia controllability, rapid recovery after surgery and it becomes effective quickly. However, it can inhibit the human respiratory and circulatory system ([@b25-ol-0-0-10120]). Therefore, reducing the amount of anesthetic drugs can contribute to the safety of the patient during surgery. EBRR and CRR in the experimental group were higher than those in the control group, and the differences were statistically significant (P\<0.05). The results showed that submucosal injection of glycerol fructose has better effect on the safety and efficacy of endoscopic surgery than normal saline. The results of the comparison between the recurrence rate of normal saline and glycerol fructose are consistent with the results of Uraoka *et al* ([@b26-ol-0-0-10120]). In this study, there was no perforation in the two groups after surgery. There was 1 case of postoperative hemorrhage in the control group, and there was no significant difference in the incidence rates of postoperative complications between the two groups. However, studies have shown that submucosal injection of glycerol fructose can reduce surgical complications ([@b27-ol-0-0-10120]). Also, there was no significant difference in the average length of hospitalization between the two groups. After 3 months of follow-up, there was no statistically significant difference in the recurrence rate between the two groups and incision wounds healed well in both groups. The effect of different submucosal injections on endoscopic digestive tract polypectomy were previously evaluated, and the patients were followed up for 6 months and no recurrence was found in either group ([@b10-ol-0-0-10120]).

In this study, we compared the general clinical information, the amount of injection and propofol used in two groups. We also compared the complications, the average length of hospitalization and recurrence rates between the two groups. A more comprehensive analysis was performed on the effects of the injection of glycerol fructose and normal saline on endoscopic resection of polyps in patients in the large intestine. There are, still relatively few comparative studies between the two groups and still many problems worthy of further study. Therefore, it is crucial to find the best treatment and submucosal injection.

In conclusion, endoscopic colorectal polypectomy with glycerol fructose as a submucosal injection can shorten the surgery time, decrease the number of repeated injections, reduce the amount of injections and dosage of propofol and increase EBRR and CRR.
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###### 

Comparison of general information between experimental and control group \[n (%), mean ± standard deviation\].

  Characteristics                           Experimental group (n=150)   Control group (n=125)   χ^2^/t   P-value
  ----------------------------------------- ---------------------------- ----------------------- -------- ---------
  Sex                                                                                            2.499    0.114
    Male                                      98 (65.3)                  70 (56.0)                        
    Female                                    52 (34.7)                  55 (44.0)                        
  Average age (years)                         58.2±6.12                    58.8±5.98             0.818    0.414
  Average weight (kg)                         75.12±6.48                   74.78±6.52            0.432    0.666
  Average height (cm)                       165.41±3.76                    166.12±3.82           1.548    0.123
  Smoking or non-smoking                                                                         0.367    0.545
    Smoking                                   87 (58.0)                  77 (61.6)                        
    Non-smoking                               63 (42.0)                  48 (38.4)                        
  Alcoholic or non-alcoholic                                                                     0.199    0.655
    Alcoholic                               128 (85.3)                   109 (87.2)                       
    Non-alcoholic                             22 (14.7)                    16 (12.8)                      
  Average polyp diameter (cm)                 0.93±0.23                    0.98±0.21             1.867    0.630
  Pathological examination classification                                                                 
    Hypertrophic polyp                        78 (52.0)                  66 (52.8)               0.017    0.895
    Benign polyp                              59 (39.3)                  49 (39.2)               0.001    0.982
    Adenomatous polyp                       13 (8.7)                     10 (8.0)                0.040    0.842
  Pathological type                                                                              0.059    0.808
    Multiple                                  44 (29.3)                  35 (28.0)                        
    Single                                  106 (70.7)                   90 (72.0)                        
  Area of pathogenesis                                                                                    
    Rectum                                    26 (17.3)                  20 (16.0)               0.087    0.768
    Sigmoid colon                             60 (40.0)                  51 (40.8)               0.018    0.893
    Descending colon                          19 (12.7)                  16 (12.8)               0.001    0.974
    Ascending colon                           25 (16.7)                  22 (17.6)               0.042    0.839
    Transverse colon                          20 (13.3)                  16 (12.8)               0.017    0.896

###### 

Comparison of surgery conditions between experimental and control group (mean ± standard deviation).

  Groups               No. of cases   Time till colonscope insertion reached ileocecal valve (min)   Time of processing polyps (min)   Total surgery time (anesthesia time) (min)   No. of repeated injections
  -------------------- -------------- -------------------------------------------------------------- --------------------------------- -------------------------------------------- ----------------------------
  Experimental group   150            6.52±1.72                                                      3.61±0.59                         16.24±1.71                                   1 (0.7)
  Control group        125            6.59±1.75                                                      7.42±0.98                         21.08±2.21                                   7 (5.6)
  t/χ^2^                              0.333                                                          39.76                             20.46                                        5.875
  P-value                             0.739                                                            \<0.001                           \<0.001                                    0.015

###### 

Comparison of the amounts of fluid and propofol injected in patients of the experimental and control group (mean ± standard deviation).

  Groups               No. of cases   Injection volume (ml)   Propofol dosage (mg)
  -------------------- -------------- ----------------------- ----------------------
  Experimental group   150            3.66±0.41               148.65±15.23
  Control group        125            5.87±0.55               165.23±42.34
  t                                   38.12                     4.463
  P-value                               \<0.001               \<0.001

###### 

Comparison of postoperative complications between experimental and control group \[n (%)\].

  Groups               No. of cases   Black stool   Stomach ache   Bloody stool   Perforation   Postoperative bleeding   Incidence rate (%)
  -------------------- -------------- ------------- -------------- -------------- ------------- ------------------------ --------------------
  Experimental group   150            2 (1.3)       5 (3.3)        1 (0.7)        0 (0.0)       0 (0.0)                  5.3
  Control group        125            3 (2.4)       4 (3.2)        2 (1.6)        0 (0.0)       1 (0.8)                  8.0
  χ^2^                                                                                                                   0.740
  P-value                                                                                                                0.390

###### 

Comparison of the average length of hospitalization and recurrence rate between the experimental and control group (mean ± standard deviation).

  Groups               No. of cases   Average length of hospitalization (days)   Recurrence rate (%)
  -------------------- -------------- ------------------------------------------ ---------------------
  Experimental group   150            3.63±0.49                                  0.00
  Control group        125            3.54±0.43                                  1.60
  χ^2^/t                              1.603                                      2.02
  P-value                             0.110                                      0.155
